诺氟沙星预防肝硬化并发自发性细菌性腹膜炎30例临床观察
出处
《中国现代药物应用》
2010年第22期138-139,共2页
Chinese Journal of Modern Drug Application
参考文献4
-
1梁扩寰主编.消化疾病诊断指南.北京:科学出版社,1999.297.
-
2Rimola A,Garca-Tsao G,Navasa M,et al.Diagnosis treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document.International Ascites Club.Hepatol,2000,32:142.
-
3陈倩,邹健,张渊.肝硬化并发自发性细菌性腹膜炎的诊治进展[J].中华全科医师杂志,2004,3(4):255-257. 被引量:14
-
4龙焜,李万亥.临床药物手册修订版.中国人民解放军后勤部.金质出版社,2008:96.
二级参考文献21
-
1王小红,李梦东.自发性细菌性腹膜炎的抗生素疗法[J].国外医学(流行病学.传染病学分册),1995,22(2):77-80. 被引量:13
-
2姚希贤.136例肝硬变腹水并发自发性细菌性腹膜炎分析[J].中华消化杂志,1990,10(1):161-161.
-
3Weinstein MP, Reller LB, Murphy JR, et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I.laboratory and epidemiolo-gic observations .Rev Infect Dis, 1983,5:35-53.
-
4Aparicio JR, Such J, Gutierrez A, et al. Development of escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination. Med Clin(Barc), 1999,113:241-245.
-
5Martin L, Sanchez E, Casafont F, et al. Develompment of spontaneous bacterial peritonitis in an experimental model in cirrhotic rats. Relationship with intestinal bacterial translocation. Rev Esp Enferm Dig, 1995,87:632-636.
-
6Bolognesi M, Merkel C, Bianco S, et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology, 1994,19:628-634.
-
7Chang CS, Yang SS, Kao CH, et al. Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol, 2001,36:92-96.
-
8Castellote J, Lopez C, Gornals J, et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology, 2003,37:893-896.
-
9Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterology Clin North Am, 1992, 21: 257-275.
-
10Holland DJ, Sorrell TC. Antimicrobial therapy and prevention of spontaneous bacterial peritonitis.J Gastroenterol Hepatol, 1993, 8: 370-374.
共引文献15
-
1陈爱静,陈梅英.慢性重型肝炎并发自发性细菌性腹膜炎病原学分析[J].实用医技杂志,2006,13(16):2807-2808.
-
2张玲.78例晚期肝病患者并发自发性腹膜炎的临床分析[J].中国医药导报,2007,4(03X):21-21. 被引量:1
-
3黄希田,颜鸣鹤,凌乔.肝硬化合并自发性细菌性腹膜炎临床特点分析[J].浙江临床医学,2007,9(7):905-905.
-
4庞家武,黄杰安.肝硬化腹水并自发性细菌性腹膜炎86例临床分析[J].内科,2008,3(3):362-364. 被引量:4
-
5闫新.肝硬化并发自发性腹膜炎腹水培养的病原菌及耐药性分析[J].中国实用医药,2009,4(21):11-12. 被引量:3
-
6张逸强.78例肝硬化并发自发性腹膜炎的临床分析[J].中国现代医生,2009,47(22):132-132. 被引量:2
-
7戚颖.肝炎患者的抗菌药物应用情况分析[J].医药论坛杂志,2010,31(15):168-169.
-
8刘慧.诺氟沙星预防肝硬化并发自发性细菌性腹膜炎30例临床观察[J].中国现代药物应用,2010,4(18):148-148.
-
9胡大山,顾生旺,蒋兆荣.肝硬化腹水合并自发性细菌性腹膜炎45例临床分析[J].肝脏,2010,15(6):474-474. 被引量:6
-
10董志超.肝硬化并发自发性腹膜炎腹水培养的病原菌及其耐药性分析[J].中国实用医药,2011,6(18):187-188. 被引量:5
-
1金根源,任德坤,王忠,杨忠礼,黄星,李全,史丕裕,谷登洋.抗个体型抗体的抗布氏菌感染作用[J].中国地方病防治,1990,5(6):343-344. 被引量:6
-
2刘慧.诺氟沙星预防肝硬化并发自发性细菌性腹膜炎30例临床观察[J].中国现代药物应用,2010,4(18):148-148.
-
3侯小藏,陈领然.中西医结合疗法对慢阻肺预防呼吸道感染作用的评价[J].辽宁中医杂志,2007,34(8):1129-1129. 被引量:3
-
4陈硕琪,陈晓春.舒普深治疗老年人下呼吸道感染的临床疗效观察(附82例分析)[J].福建医药杂志,2000,22(6):28-29. 被引量:1
-
5段晶莹.慢性非特异性溃疡性结肠炎38例治疗体会[J].基层医学论坛,2004,8(10):951-952.
-
6陈海平.喜炎平注射液佐治婴幼儿肺炎100例疗效观察[J].南京医科大学学报(自然科学版),2007,27(3):280-281. 被引量:28
-
7病毒性肝炎——总论[J].传染病网络动态,2006(4):86-90.
-
8袁金明,张金安.两种免疫程序接种乙肝疫苗效果比较[J].解放军护理杂志,2004,21(10):67-68. 被引量:4
-
9温中薇.经纤维支气管镜肺灌洗治疗老年肺炎并呼吸衰竭疗效分析[J].当代医学,2016,22(15):78-79. 被引量:3
-
10孙茂倬,杨光宏,李凤莲,刘景福,巩翠华.肾综合征出血热亚中和水平抗体增强病毒感染的实验研究[J].中国公共卫生,1999,15(9):797-798.